date:Mar 14, 2014
turing capabilities.
Effectively competing in the animal vaccine segment is a cornerstone of Elancos long-term strategy and is one more way we will expand the value we create for customers, said Jeff Simmons, senior vice president of Eli Lilly and Company and president of Elanco Animal Health.
The addition of Lohmann Animal Health provides a unique opportunity for Elanco to expand our presence in the global poultry market and to enter the global poultry vaccine market with a solid base, establ